These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 12160695)
1. Use of a GABA-transaminase agonist for treatment of infantile autism. Cohen BI Med Hypotheses; 2002 Jul; 59(1):115-6. PubMed ID: 12160695 [TBL] [Abstract][Full Text] [Related]
2. GABA-transaminase, the liver and infantile autism. Cohen BI Med Hypotheses; 2001 Dec; 57(6):673-4. PubMed ID: 11918424 [TBL] [Abstract][Full Text] [Related]
3. The significance of ammonia/gamma-aminobutyric acid (GABA) ratio for normality and liver disorders. Cohen BI Med Hypotheses; 2002 Dec; 59(6):757-8. PubMed ID: 12445521 [TBL] [Abstract][Full Text] [Related]
5. Effects of phenelzine and imipramine on the steady-state levels of mRNAs that encode glutamic acid decarboxylase (GAD67 and GAD65), the GABA transporter GAT-1 and GABA transaminase in rat cortex. Lai CT; Tanay VA; Charrois GJ; Baker GB; Bateson AN Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):32-8. PubMed ID: 9459570 [TBL] [Abstract][Full Text] [Related]
6. The effects of GABA agonists on glutamic acid decarboxylase, GABA-transaminase, activin, salmon gonadotrophin-releasing hormone and tyrosine hydroxylase mRNA in the goldfish (Carassius auratus) neuroendocrine brain. Martyniuk CJ; Chang JP; Trudeau VL J Neuroendocrinol; 2007 May; 19(5):390-6. PubMed ID: 17425614 [TBL] [Abstract][Full Text] [Related]
7. Imipramine in preschool autistic and schizophrenic children. Campbell M; Fish B; Shapiro T; Floyd A J Autism Child Schizophr; 1971; 1(3):267-82. PubMed ID: 5172531 [No Abstract] [Full Text] [Related]
8. Muscimol-like discriminative stimulus effects of GABA agonists in rats. Jones HE; Balster RL Pharmacol Biochem Behav; 1998 Feb; 59(2):319-26. PubMed ID: 9476976 [TBL] [Abstract][Full Text] [Related]
9. [Regulation of the mouse aggressive behavior (pharmacologic analysis of the GABAergic mechanism)]. Belozertseva IV; Andreev BV Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(5):780-8. PubMed ID: 10570533 [TBL] [Abstract][Full Text] [Related]
12. Effects of the antidepressant/antipanic drug phenelzine on GABA concentrations and GABA-transaminase activity in rat brain. McManus DJ; Baker GB; Martin IL; Greenshaw AJ; McKenna KF Biochem Pharmacol; 1992 Jun; 43(11):2486-9. PubMed ID: 1610412 [TBL] [Abstract][Full Text] [Related]
13. Kinetic studies on the inhibition of GABA-T by gamma-vinyl GABA and taurine. Sulaiman SA; Suliman FE; Barghouthi S J Enzyme Inhib Med Chem; 2003 Aug; 18(4):297-301. PubMed ID: 14567543 [TBL] [Abstract][Full Text] [Related]
14. GABA(B) receptor mechanism and imipramine-induced antinociception in ligated and non-ligated mice. Zarrindast M; Valizadeh S; Sahebgharani M Eur J Pharmacol; 2000 Oct; 407(1-2):65-72. PubMed ID: 11050292 [TBL] [Abstract][Full Text] [Related]
15. Psychopharmacological treatment of psychotic children. A survey. Jørgensen OS Acta Psychiatr Scand; 1979 Feb; 59(2):229-38. PubMed ID: 33538 [TBL] [Abstract][Full Text] [Related]
16. Platelet dopamine uptake in autistic and other psychotic children. Inhibition by imipramine. Szekely GA; Caplan R; Rotman A Prog Neuropsychopharmacol; 1980; 4(2):215-8. PubMed ID: 7403355 [No Abstract] [Full Text] [Related]
17. Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia. Costa C; Leone G; Saulle E; Pisani F; Bernardi G; Calabresi P Stroke; 2004 Feb; 35(2):596-600. PubMed ID: 14726544 [TBL] [Abstract][Full Text] [Related]
18. [Imipramine in the therapy of schizophrenic psychoses]. Schmidt P Psychiatr Neurol Med Psychol Beih; 1975; 20-21():238-44. PubMed ID: 829630 [TBL] [Abstract][Full Text] [Related]
19. Attenuation of γ-aminobutyric acid (GABA) transaminase activity contributes to GABA increase in the cerebral cortex of mice exposed to β-cypermethrin. Han Y; Cao D; Li X; Zhang R; Yu F; Ren Y; An L Hum Exp Toxicol; 2014 Mar; 33(3):317-24. PubMed ID: 24220872 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form]. Desjardins S; Doyen C; Contejean Y; Kaye K; Paubel P Encephale; 2009 Apr; 35(2):168-72. PubMed ID: 19393386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]